Notably, Spike S1+CD31+ EVs levels were significantly increased in pre‐13 days COVID‐19 group compared to healthy controls and post‐13 days COVID‐19, but not with the immune markers analysed (Figure S5). The gene discussed is PECAM1; the disease is COVID-19.